Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms
暂无分享,去创建一个
Irina S. Moreira | Maria J. Ramos | Isabel Santos | Pedro A. Fernandes | I. Moreira | B. Oliveira | J. Correia | P. Fernandes | M. Ramos | I. Santos | Bruno L. Oliveira | João D. G. Correia
[1] G. Desiraju,et al. Insights into ligand selectivity in nitric oxide synthase isoforms: a molecular dynamics study. , 2007, Journal of molecular graphics & modelling.
[2] Richard Graham Knowles,et al. 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.
[3] M. Botta,et al. Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors. , 2006, Current medicinal chemistry.
[4] J. Leiper,et al. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis , 2011, Nature Reviews Drug Discovery.
[5] Piotr Cieplak,et al. R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments , 2011, Nucleic Acids Res..
[6] António E. N. Ferreira,et al. Re and Tc tricarbonyl complexes: from the suppression of NO biosynthesis in macrophages to in vivo targeting of inducible nitric oxide synthase. , 2010, Bioconjugate chemistry.
[7] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[8] T. Poulos,et al. Crystal Structures of Zinc-free and -bound Heme Domain of Human Inducible Nitric-oxide Synthase , 1999, The Journal of Biological Chemistry.
[9] S. Nosé. A molecular dynamics method for simulations in the canonical ensemble , 1984 .
[10] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[11] C. Thiemermann,et al. Nitric oxide synthase inhibitors. , 2000, Methods in molecular medicine.
[12] T. Poulos,et al. Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas. , 2000, Journal of inorganic biochemistry.
[13] P. Weber,et al. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation , 1999, Nature Structural Biology.
[14] Piotr Cieplak,et al. R.E.DD.B.: A database for RESP and ESP atomic charges, and force field libraries , 2007, Nucleic Acids Res..
[15] T. Poulos,et al. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. , 2008, Journal of the American Chemical Society.
[16] António E. N. Ferreira,et al. Targeting nitric oxide synthase with 99mTc/Re-tricarbonyl complexes containing pendant guanidino or isothiourea moieties , 2011 .
[17] T. Poulos,et al. Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model. , 2010, Journal of the American Chemical Society.
[18] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[19] James B. Mitchell,et al. Nitric oxide and cancer: an introduction. , 2003, Free radical biology & medicine.
[20] James Leiper,et al. Blocking NO synthesis: how, where and why? , 2002, Nature Reviews Drug Discovery.
[21] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[22] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[23] K. Sharp,et al. Travel depth, a new shape descriptor for macromolecules: application to ligand binding. , 2006, Journal of molecular biology.
[24] T. Poulos,et al. Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives. , 2010, Journal of medicinal chemistry.
[25] J. Zicha,et al. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats. , 2003, Clinical science.
[26] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[27] T. Poulos,et al. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. , 2001, Biochemistry.
[28] Roman Fedorov,et al. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases. , 2005, Journal of medicinal chemistry.
[29] Hoover,et al. Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.
[30] V. Granik,et al. Nitric oxide synthase inhibitors: biology and chemistry , 2002 .
[31] J. Macdonald. CHAPTER 23. NITRIC OXIDE SYNTHASE INHIBITORS , 1996 .
[32] Gerhard Klebe,et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations , 2007, Nucleic Acids Res..
[33] Haitao Ji,et al. Selective neuronal nitric oxide synthase inhibitors. , 2005, Current topics in medicinal chemistry.
[34] Jeremy R. Greenwood,et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..
[35] Piotr Cieplak,et al. The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. , 2010, Physical chemistry chemical physics : PCCP.
[36] P. Kollman,et al. Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation , 1993 .
[37] Jan H. Jensen,et al. Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.
[38] Kremer,et al. Molecular dynamics simulation for polymers in the presence of a heat bath. , 1986, Physical review. A, General physics.
[39] T. Poulos,et al. Structure-function studies on nitric oxide synthases. , 2005, Journal of inorganic biochemistry.
[40] Edsger W. Dijkstra,et al. A note on two problems in connexion with graphs , 1959, Numerische Mathematik.
[41] Alexander D. MacKerell,et al. CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..
[42] V. Cardile,et al. Novel Inhibitors of Neuronal Nitric Oxide Synthase , 2003, Experimental biology and medicine.
[43] T. Poulos,et al. Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase. , 2010, Journal of the American Chemical Society.
[44] M. Moskowitz,et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.
[45] Nathan A. Baker,et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..
[46] Garrett M Morris,et al. Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency. , 2002, Biochemistry.
[47] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[48] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.
[49] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[50] B. Brooks,et al. Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .
[51] J. Tainer,et al. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase , 2008, Nature chemical biology.
[52] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[53] S. Shaik,et al. Compound I of nitric oxide synthase: the active site protonation state. , 2007, Journal of the American Chemical Society.
[54] I. Schlichting,et al. Structural Basis for the Specificity of the Nitric-oxide Synthase Inhibitors W1400 and Nω-Propyl-l-Arg for the Inducible and Neuronal Isoforms* , 2003, Journal of Biological Chemistry.